Magnesium Glycinate Market Share

North American Market Forecast   

North America industry is anticipated to account for largest revenue share of 38% by 2037, attributed to increasing adoption of magnesium glycinate for various applications such as the treatment of NCDs, diabetes, osteoporosis, and usage as an‚Â antidepressant‚ in the pharmaceutical industry. The growth of the market can be attributed majorly to the increasing adoption of magnesium glycinate for various applications such as the treatment of NCDs, diabetes, osteoporosis, and usage as an antidepressant in the pharmaceutical industry; magnesium glycinate as an amino acid resource which is essential for manufacturing personal care products and observed a rising use of magnesium glycinate in the packed food products as food additives in this region. It was observed that, in 2018, 51.8% (129 million) of civilian, noninstitutionalized adults were identified with at least one of ten chronic or NCD conditions in US. Magnesium is prescribed to pregnant patients to prevent magnesium deficiency. The increasing percentage of pregnant people in the region owing to the highest teen pregnancy is estimated to drive the market growth. Also, as per the estimations, there are more people in the United States with a deficiency of magnesium.